Patrick Collison — Why Silicon Valley's most talented should leave

Patrick Collison, co-founder and CEO of Stripe, recently said something you don’t often hear from a Silicon Valley insider: people in their 20s might want to reconsider moving to San Francisco. He’s not dismissing startups—after all, he built Stripe into a payments giant—but throughout his conversation with Dwarkesh Patel, he kept circling back to a warning. If a culture only celebrates 20-year-old dropouts writing code and becoming CEOs, who will push forward the fields that demand decades in a lab?

Collison’s central worry is that Silicon Valley’s dominant narrative overglorifies the young disruptor, making it feel like not launching a startup is a failure of nerve. He points to biotech: Genentech co-founder Herb Boyer didn’t invent recombinant DNA on a sudden flash of insight in his 20s; it came after years of accumulated knowledge and bench work. Collison also mentions Arc Institute’s Patrick Hsu—scientists like them spend long apprenticeships learning not just techniques but how to judge which problems are worth a decade of effort. He references the book ‘Apprentice to Genius’ to highlight how top scientists pass down subtle instincts: what truly high standards look like, how to pick a question that matters. You can’t learn that from online tutorials. You have to be immersed in a first-rate lab, pushed by mentors who won’t settle for good enough.

Yet he admits that avoiding the herd is harder than it sounds. Everyone knows not to follow the crowd, but in practice you can easily end up being a reflexive contrarian—just inverting the prevailing mood without really thinking for yourself. Collison doesn’t offer a formula, but he urges people to be skeptical of what he calls a “San Francisco mindset”: the assumption that entrepreneurship is the only high-status path, while a decade of solitary work in an obscure discipline could end up changing the world just as much. Naturally, some will push back: didn’t Silicon Valley produce Stripe itself, or Facebook? Young founders can upend industries. Collison doesn’t deny that; he simply thinks the scales have tipped too far. Software and consumer internet may reward fast iteration, but biology, medicine, materials science—those don’t. He also hints at the limits of institutions like the NIH, where more funding doesn’t automatically mean more Herb Boyers.

In the end, Collison’s advice isn’t a one-size-fits-all prescription. He wants people to ask seriously: for the problem you truly care about, what environment will teach you the highest standards? Is it joining a top lab as an apprentice under a demanding mentor, or diving into a startup to iterate? There is no algorithm for this, but the worst choice is to drift along with whatever you’re “supposed” to do. His honesty is striking: a symbol of Silicon Valley success standing up to say its story isn’t the only truth. That itself is a kind of nonconformity—not reflexive rebellion, but a reminder that some fruits take a decade to ripen, and we need to give those fields a bit more patience and applause.